89. Kelsey Ramsden, CEO of MINDCURE
Today I'm joined by Kelsey Ramsden, CEO of MINDCURE — a life sciences company using psychedelics to promote healing and improve mental health.
In this episode, we discuss the psychedelic revolution, including shifts in science and culture paving the way. Kelsey explains the challenges and opportunities facing operators and investors in this space. And she talks about MINDCURE's efforts to build digital therapeutics that support psychedelic-assisted therapies.
More from Kelsey
With over fifteen years founding, scaling, and operating innovative companies across Canada and the Caribbean, Ramsden…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.